Clinical Trials Directory

Trials / Completed

CompletedNCT00563420

Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Hospital Authority, Hong Kong · Other Government
Sex
All
Age
40 Years
Healthy volunteers

Summary

Lung cancer is the commonest malignant disease with a 5-year survival of 14%. In Hong Kong, it accounts for about 30% of all cancer death. The poor prognosis of lung cancer is due largely to the late clinical presentation of the disease. In order to improve the prognosis of lung cancer, an obvious approach is to develop sensitive methods for detecting lung cancer at much earlier stages when treatment is more likely to be curative. However, the best way for identifying early lung cancer is still need to be determined. We hypothesis that by examining specimens that contain shed bronchial epithelial cells i.e. sputum, lung cancer can be sampled in its earliest possible phase. And by using autofluorescence bronchoscopy, a system specifically designed to detect early lung cancer/pre-invasive lesions, to identify the source of abnormal cells, we may able to detect eraly lung cancer and followed by curative treatment to improve the prognosis of this disease.

Conditions

Interventions

TypeNameDescription
PROCEDUREBronchoscopy

Timeline

Start date
2002-11-01
Completion
2007-06-01
First posted
2007-11-26
Last updated
2013-10-23

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00563420. Inclusion in this directory is not an endorsement.

Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of (NCT00563420) · Clinical Trials Directory